尿路上皮癌中的免疫肿瘤学：谁或什么最终将坐上铁王座？ - Suppr

Immuno-oncology in urothelial carcinoma: who or what will ultimately sit on the iron throne?

作者信息

Ramos Jorge D, Yu Evan Y

机构信息

Fred Hutchinson Cancer Research Center, Seattle, WA, USA.

Department of Medicine, Division of Oncology, University of Washington School of Medicine, Seattle Cancer Care Alliance, 825 Eastlake Ave E - G4-800, Seattle, WA 98109-1024, USA.

出版信息

Immunotherapy. 2017 Sep;9(12):951-954. doi: 10.2217/imt-2017-0109.

DOI:10.2217/imt-2017-0109

PMID:28971748

Abstract

摘要

相似文献

Immuno-oncology in urothelial carcinoma: who or what will ultimately sit on the iron throne?

Immunotherapy. 2017 Sep;9(12):951-954. doi: 10.2217/imt-2017-0109.

The benefits of immunotherapy combinations.

Nature. 2017 Dec 21;552(7685):S67-S69. doi: 10.1038/d41586-017-08702-7.

#Checkmate: could checkpoint inhibitors be the game changer in the fight against metastatic urothelial carcinoma?

BJU Int. 2019 Feb;123(2):203-207. doi: 10.1111/bju.14463. Epub 2018 Oct 26.

Immunotherapy Advances in Urothelial Carcinoma.

Curr Treat Options Oncol. 2018 Dec 15;19(12):79. doi: 10.1007/s11864-018-0598-x.

Emerging role of checkpoint inhibition in localized bladder cancer.

Urol Oncol. 2016 Dec;34(12):548-555. doi: 10.1016/j.urolonc.2016.09.004. Epub 2016 Oct 21.

Immunotherapy for Urothelial Carcinoma: Current Evidence and Future Directions.

Curr Urol Rep. 2018 Nov 7;19(12):109. doi: 10.1007/s11934-018-0851-7.

From Clinical Trials to Real-life Clinical Practice: The Role of Immunotherapy with PD-1/PD-L1 Inhibitors in Advanced Urothelial Carcinoma.

Eur Urol Oncol. 2018 Dec;1(6):486-500. doi: 10.1016/j.euo.2018.05.011. Epub 2018 Jul 2.

A network meta-analysis of the PD(L)-1 inhibitors in the salvage treatment of urothelial bladder cancer.

Immunotherapy. 2018 Jun;10(8):657-663. doi: 10.2217/imt-2017-0190. Epub 2018 Mar 22.

From the Uncertainties to the Evidence: A Brief History of Immunotherapy as Salvage Therapy for Advanced Bladder Cancer Through a Meta-analysis.

Clin Genitourin Cancer. 2017 Oct;15(5):509-512.e9. doi: 10.1016/j.clgc.2017.04.008. Epub 2017 Apr 13.

Outside the box of immunotherapy - new hope for patients with advanced urothelial cancer.

Acta Oncol. 2019 Jul;58(7):951-952. doi: 10.1080/0284186X.2019.1631478. Epub 2019 Jun 24.

引用本文的文献

Efficacy of Platinum Rechallenge in Metastatic Urothelial Carcinoma After Previous Platinum-Based Chemotherapy for Metastatic Disease.

Oncologist. 2021 Dec;26(12):1026-1034. doi: 10.1002/onco.13925. Epub 2021 Aug 17.

Immunotherapy-Related Imaging Findings in Patients with Gynecological Malignancies: What Radiologists Need to Know.

Korean J Radiol. 2021 Aug;22(8):1310-1322. doi: 10.3348/kjr.2020.1299. Epub 2021 May 20.

Cell Therapies in Bladder Cancer Management.

Int J Mol Sci. 2021 Mar 10;22(6):2818. doi: 10.3390/ijms22062818.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Immuno-oncology in urothelial carcinoma: who or what will ultimately sit on the iron throne?

作者信息

Ramos Jorge D, Yu Evan Y

机构信息

Fred Hutchinson Cancer Research Center, Seattle, WA, USA.

Department of Medicine, Division of Oncology, University of Washington School of Medicine, Seattle Cancer Care Alliance, 825 Eastlake Ave E - G4-800, Seattle, WA 98109-1024, USA.

出版信息

Immunotherapy. 2017 Sep;9(12):951-954. doi: 10.2217/imt-2017-0109.

DOI:10.2217/imt-2017-0109

PMID:28971748

Abstract

摘要

相似文献

Immuno-oncology in urothelial carcinoma: who or what will ultimately sit on the iron throne?

Immunotherapy. 2017 Sep;9(12):951-954. doi: 10.2217/imt-2017-0109.

The benefits of immunotherapy combinations.

Nature. 2017 Dec 21;552(7685):S67-S69. doi: 10.1038/d41586-017-08702-7.

#Checkmate: could checkpoint inhibitors be the game changer in the fight against metastatic urothelial carcinoma?

BJU Int. 2019 Feb;123(2):203-207. doi: 10.1111/bju.14463. Epub 2018 Oct 26.

Immunotherapy Advances in Urothelial Carcinoma.

Curr Treat Options Oncol. 2018 Dec 15;19(12):79. doi: 10.1007/s11864-018-0598-x.

Emerging role of checkpoint inhibition in localized bladder cancer.

Urol Oncol. 2016 Dec;34(12):548-555. doi: 10.1016/j.urolonc.2016.09.004. Epub 2016 Oct 21.

Immunotherapy for Urothelial Carcinoma: Current Evidence and Future Directions.

Curr Urol Rep. 2018 Nov 7;19(12):109. doi: 10.1007/s11934-018-0851-7.

From Clinical Trials to Real-life Clinical Practice: The Role of Immunotherapy with PD-1/PD-L1 Inhibitors in Advanced Urothelial Carcinoma.

Eur Urol Oncol. 2018 Dec;1(6):486-500. doi: 10.1016/j.euo.2018.05.011. Epub 2018 Jul 2.

A network meta-analysis of the PD(L)-1 inhibitors in the salvage treatment of urothelial bladder cancer.

Immunotherapy. 2018 Jun;10(8):657-663. doi: 10.2217/imt-2017-0190. Epub 2018 Mar 22.

From the Uncertainties to the Evidence: A Brief History of Immunotherapy as Salvage Therapy for Advanced Bladder Cancer Through a Meta-analysis.

Clin Genitourin Cancer. 2017 Oct;15(5):509-512.e9. doi: 10.1016/j.clgc.2017.04.008. Epub 2017 Apr 13.

Outside the box of immunotherapy - new hope for patients with advanced urothelial cancer.

Acta Oncol. 2019 Jul;58(7):951-952. doi: 10.1080/0284186X.2019.1631478. Epub 2019 Jun 24.

引用本文的文献

Efficacy of Platinum Rechallenge in Metastatic Urothelial Carcinoma After Previous Platinum-Based Chemotherapy for Metastatic Disease.

Oncologist. 2021 Dec;26(12):1026-1034. doi: 10.1002/onco.13925. Epub 2021 Aug 17.

Immunotherapy-Related Imaging Findings in Patients with Gynecological Malignancies: What Radiologists Need to Know.

Korean J Radiol. 2021 Aug;22(8):1310-1322. doi: 10.3348/kjr.2020.1299. Epub 2021 May 20.

Cell Therapies in Bladder Cancer Management.

Int J Mol Sci. 2021 Mar 10;22(6):2818. doi: 10.3390/ijms22062818.

Immuno-oncology in urothelial carcinoma: who or what will ultimately sit on the iron throne?

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

Immuno-oncology in urothelial carcinoma: who or what will ultimately sit on the iron throne?

作者信息

机构信息

出版信息

相似文献

引用本文的文献